You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020321044
Dec 202036012
Jan 202125017
Feb 20213608
Mar 202190014
Apr 202156010
May 202119012
Jun 2021004
Jul 2021009
Aug 20210010
Sep 20210012
Oct 202116020
Nov 202128020
Dec 20213409
Jan 20222806
Feb 20221808
Mar 20221002
Apr 20223204
May 20222601
Jun 20222602
Jul 20221405
Aug 20222605
Sep 20221603
Oct 20221401
Nov 20221403
Dec 20221800
Jan 20232400
Feb 20232802
Mar 20233403
Apr 20231000
May 20233804
Jun 20232203
Jul 20232004
Aug 20231004
Sep 2023801
Oct 20232603
Nov 20231602
Dec 20234403
Jan 20241001
Feb 20243400
Mar 20243208
Apr 20241201
May 20242203
Jun 20244600
Jul 20242802
Aug 20242202
Sep 20241401
Oct 20243006
Nov 20241903
Dec 20241406
Jan 20251402
Feb 2025603
Mar 2025005
Apr 2025008
May 2025003
Jun 2025003
Total14860327